Abubakar, Zamesa M.
HRN: 24-83-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2024
CO-AMOXICLAV 625MG (TAB)
04/07/2024
04/09/2024
ORAL
625 Mg Tablet
2x A Day
Empiric
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes